• Paldara, Mayo Clinic Push Phage Therapy Toward First Human Trials

    Clinical Research News | Phage therapy, a treatment that uses viruses to fight bacterial infections, may finally be heading toward mainstream clinical practice. Paldara, a biotech startup, is developing a delivery platform that promises to stabilize and sustain bacteriophages and make phage therapy accessible for patients.

    Sep 23, 2025

  • Paldara, Mayo Clinic Push Phage Therapy Toward First Human Trials

    Clinical Research News | Phage therapy, a treatment that uses viruses to fight bacterial infections, may finally be heading toward mainstream clinical practice. Paldara, a biotech startup, is developing a delivery platform that promises to stabilize and sustain bacteriophages and make phage therapy accessible for patients.

    Sep 23, 2025

  • Building Momentum: Strengthening Patient Retention in Clinical Trials

    Clinical Research News | In clinical research, keeping patients engaged throughout the course of a trial is not only a logistical goal but a scientific necessity. Retention ensures that datasets remain complete, representative, and reliable. High dropout rates, by contrast, mean gaps in data, higher costs to backfill participants, and extended timelines that frustrate everyone involved.

    Sep 19, 2025

  • Psilocybin Shows Potential as Candidate for Delayed Aging

    Clinical Research News | Psilocybin—the psychoactive compound found in “magic mushrooms”—has often been viewed in a negative light due to the reputation of psychedelics, even among experts. But new research suggests that the compound could have a role in slowing the aging process.

    Sep 16, 2025

  • Tackling Trial and Data Complexity in DCTs with Advanced Analytics and Machine Learning

    Clinical Research News | Advanced statistical and machine learning (ML) models offer new ways to cope with an evolving and increasingly complex clinical trial data landscape. It enables us to interrogate new, complex and raw data sources, perform complex data reviews, learn from past studies and process large volumes of data.

    Sep 12, 2025

  • The Scope of Things: A Global Movement to Cure Multiple Myeloma

    Clinical Research News | In this month’s episode of The Scope of Things podcast, Joseph Mikhael, chief medical officer of the International Myeloma Foundation (IMF), discusses how the Black Swan Research Initiative (BSRI), a global scientific alliance dedicated to finding a cure for multiple myeloma, and global collaborators are making strides in multiple myeloma research and prevention efforts.

    Sep 10, 2025

  • The Scope of Things: A Global Movement to Cure Multiple Myeloma

    Clinical Research News | In this month’s episode of The Scope of Things podcast, Joseph Mikhael, chief medical officer of the International Myeloma Foundation (IMF), discusses how the Black Swan Research Initiative (BSRI), a global scientific alliance dedicated to finding a cure for multiple myeloma, and global collaborators are making strides in multiple myeloma research and prevention efforts.

    Sep 10, 2025